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ABSTRACT:
Cysteine is a uniquely reactive amino acid, capable of
undergoing both nucleophlilic and oxidative post-
translational modifications. One such oxidation reaction
involves the covalent modification of cysteine via the gas-
eous second messenger nitric oxide (NO), termed S-nitro-
sylation (SNO). This dynamic post-translational
modification is involved in the redox regulation of pro-
teins across all phylogenic kingdoms. In mammals,
calcium-dependent activation of NO synthase triggers the
local release of NO, which activates nearby guanylyl
cyclases and cGMP-dependent pathways. In parallel, dif-
fusible NO can locally modify redox active cellular thiols,
functionally modulating many redox sensitive enzymes.
Aberrant SNO is implicated in the pathology of many
diseases, including neurodegeneration, inflammation,
and stroke. In this review, we discuss current methods to
label sites of SNO for biochemical analysis. The most
popular method involves a series of biochemical steps to
mask free thiols followed by selective nitrosothiol reduc-
tion and capture. Other emerging methods include
mechanism-based phosphine probes and mercury enrich-
ment chemistry. By bridging new enrichment approaches
with high-resolution mass spectrometry, large-scale anal-
ysis of protein nitrosylation has highlighted new pathways
of oxidative regulation.VC 2013 Wiley Periodicals, Inc.
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INTRODUCTION
S
ulfur is the lightest element that can produce stable
exceptions to the octet rule because of the presence
of “d” orbitals. Typical cysteine residues in proteins
have a side chain pKa values of 8.0,
1 and thus 10%
of cysteine thiols are in their reactive thiolate form at
physiological pH. However, many redox active or catalytic
cysteine residues have dramatically reduced pKa values. Such
thiolates have evolved to promote catalysis or redox regula-
tion. For example, the pKa of the catalytic cysteine in methi-
onine sulfoxide reductase is reduced to 5.7 upon substrate
binding.2,3 Similarly the active site thiol of glutaredoxin has
a low pKa near 3.5.
4,5 Such altered acid-dissociation con-
stants enhance thiol reactivity, which in turn promote reac-
tions with electrophilic oxidants to produce distinct post-
translational modifications.
In this review, we focus on the chemistry and dynamics of
protein S-nitrosylation (SNO). This unique oxidative modifi-
cation directly modulates the localization and activity of cellu-
lar proteins involved in cellular growth and regulation.6,7 In
neurons, stimulus-dependent depolarization leads to calcium
influx, calmodulin activation, and stimulation of nitric oxide
(NO) synthases.8–10 Local NO release induces spatially
restricted SNO of channels, phosphatases, and other redox
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active thiols.6,11,12 Emerging proteomics studies implicate hun-
dreds of endogenous sites of nitrosylation,13–16 although the
stoichiometry and functional consequences of these post-
translational remains an active research area.
There are several mechanistic routes leading to protein
SNO (Figure 1). Heme-dependent NO synthases generate NO
via a two-step, five-electron oxidation of L-arginine.22–25 This
reaction uses two moles of molecular oxygen and 3/2 moles of
NADPH per mole of NO formed.26 NO itself is not especially
reactive towards protonated cellular thiols, particularly under
aerobic conditions.27–29 To generate nitrosothiols, NO must
first undergo secondary oxidation to nitrogen dioxide, which
occurs via at least two distinct pathways.30 In the first pathway,
NO reacts with a superoxide radical to make peroxynitrite. Per-
oxynitrite (pKa of 6.531) converts to peroxynitrous acid at
physiological pH, which undergoes hemolytic cleavage to form
the hydroxyl and the nitrogen dioxide radicals. The nitrogen
dioxide radical can in turn react with NO to form dinitrogen
trioxide, which reacts with thiolates to form nitrosothiols.29 In
a second pathway, nitrogen dioxide reacts with a thiolate to
generate nitrite and a thiyl radical.17 The resulting thiyl radical
is the only species able to react directly with NO to generate
nitrosothiols. Additionally, metal-dependent formation of thiyl
radicals32 promotes SNO by one-electron oxidation of thiols to
thiyl radicals, or through metal-nitrosyl complex intermedi-
ates.33,34 Furthermore, iron and NO spontaneously react to
form dinitrosyliron complexes (DNIC), which can be inter-
mediates in nitrosothiol formation.35–38 All of these routes
generate diffusible reactive radicals with enhanced reactivity
towards thiols with reduced pKa values, such as catalytic or
redox-active thiols.
SNO is reversible, either by NO release or by direct transfer
to other cellular thiols.39,40 Such trans-nitrosylation reactions
mobilize the exchange of NO from one protein to another,
relaying nitroso-oxidation through multiple carriers.41–44
Trans-nitrosylation provides another route for the dynamic
exchange of nitrosothiols. Millimolar glutathione levels main-
tain an intracellular reducing environment that protects pro-
teins from oxidative modifications.45 Abundant glutathione
scavenges nitrosothiols by trans-nitrosylation, yielding a
reduced protein thiol and nitrosoglutathione, which is reduced
either by S-nitrosoglutathione reductase (GSNOR) or thiore-
doxin cascades. Such thiol exchange reactions are prevalent at
physiological pH and predominate in comparison to hydrolysis
reactions,46 and are driven by the levels of reduced thiols in a
given environment.47 Several studies have demonstrated trans-
nitrosylation cascades relay the nitroso adduct from one pro-
tein thiol to another, eventually nitrosylating and inactivating
select enzymes, for example nuclear chromatin-modifying
enzymes.48 This model suggests stable SNO sites are protected
from the cellular environment, masked inside proteins or
membranes. These studies demonstrate the surprising resil-
ience of certain nitrosylated proteins in face of millimolar glu-
tathione, and hints at orchestrated pathways of nitrosothiol
transfer in cellular regulation. Indeed, hydrophobicity does
enhance the rate of reaction between NO and oxygen by several
fold,49 suggesting that thiols in hydrophobic environments,
either in membranes or in hydrophobic protein domains, may
be more prone to stable SNO.6 Overall, protein SNO is modu-
lated by thiol pKa, vicinal hydrophobicity,
6 proximity to NOS
enzymes and by activities of redox enzymes such as thiore-
doxin, GSNOR, and accessibility to reduced glutathione.
Protein nitrosylation functionally regulates protein
activities by transiently occupying thiol residues. Functional
cysteines often reside in the active sites of enzymes, such as
phosphatases, proteases, acyl-transferases, and ubiquitin
ligases.50 These thiols reside in environments that promote
thiolate formation by reducing the side-chain pKa, leading
to a more redox-active cysteine. Importantly, the active site
of any enzyme is more likely to be protected from the envi-
ronment, which likely prevents exchange with bulkier thi-
ols. Accordingly, more stable SNO is inversely correlated
with thiolate exposure, and stabilized in protected environ-
ments. Indeed, nitrosylation of cellular phosphatases poten-
tiates kinase cascades to promote cell growth, or inactivates
lipid phosphatases during ischemic stroke.51–53Because of
the selective targeting of functional cysteines, nitrosylation
may serve as a general redox switch important for the
reversible inactivation of functional cysteine residues. For
FIGURE 1 Formation of nitrosothiols from nitric oxide (NO)
occurs through distinct oxidative pathways,17–21 each involving two
molecules of NO for each nitrosothiol formed. Superoxide radical
5 O2
2•. Oxygen 5 O2.
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example, nitrosylation of glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) recruits the ubiquitin ligase Siah1,
and the GAPDH-Siah1 complex translocates to the nucleus
where Siah1 targets nuclear proteins for degradation.54–56
Similarly, argininosuccinate synthase, the enzyme that gen-
erates arginine from citrulline,57 is inhibited by SNO at
Cys132.58 Elevated NO levels induce argininosuccinate syn-
thase nitrosylation and inactivation, providing an autoregu-
latory loop that prevents excess oxidant production.
SNO can also directly compete other reversible cysteine
post-translational modifications, such as protein palmitoyl-
ation. Upon synaptic stimulation, protein palmitoyl thioester-
ases remove the membrane anchoring lipids from the neuronal
scaffolding protein PSD-95, promoting egress from the post-
synaptic density.59 Simultaneous activity-dependent calcium
influx activates neuronal NO synthase (nNOS), which is stably
associated with PSD-95 via PDZ-dependent interactions. This
locally generated flux of NO directly nitrosylates the newly
deacylated thiols, thus blocking further palmitoylation and
membrane association. The mutually competitive modification
of PSD-95 cysteines orchestrates synaptic release through an
exchange of specific cysteine post-translational modifications.59
Furthermore, SNO of the NMDA receptor leads to channel
desensitization and channel closing, preventing excitotoxicity.52
This cascade of post-translational events ensures proper mem-
brane release of PSD-95, and ensures proper channel desensiti-
zation. This example raises the question if such mutually
competitive modifications are unique for PSD-95, or if many
proteins undergo dynamic exchange of cysteine PTMs. Fur-
thermore, PSD-95 nitrosylation is channeled by protein–pro-
tein interactions, which provides selectivity for the deacylated
thiols. The breadth of cysteine modifications competition is
unknown. Interestingly, several palmitoylated proteins, includ-
ing Ras and G-proteins, are rapidly depalmitoylated after
receptor stimulation,60–62 which coincides activation of
NADPH oxidases and NO synthases.
ASCORBATE-DEPENDENT ENRICHMENT
STRATEGIES
Sensitive and selective labeling tools are critical for the precise
detection and annotation of SNO. Despite the acceptance of
SNO as an important protein regulatory modification, there
remains a lack of direct methods to study this reversible redox
modification. Early approaches used chemiluminescent, colori-
metric, or electrochemical methods to detect total NO liber-
ated from nitrosylated thiols in a sample.63 These methods
measure bulk release, and do not distinguish between heme,
metabolite, or protein sources. Furthermore, these approaches
eliminate any information about the sites and dynamics of
nitrosylation on select proteins.
The “biotin-switch” technique was a major advance in the
study and annotation of S-nitrosylated proteins.64 This widely
adopted method involves a series of biochemical steps, begin-
ning with addition of the alkylating agent 2-iodacetamide, or
by methyl methanethiosulfonate (MMTS) to block all free thi-
ols. After removing the thiol capture reagents, the sample is
treated with ascorbate, which reduces nitrosothiols to generate
free sulfhydryl groups. This approach is selective for SNO over
other oxidative modifications, largely due to the unique mech-
anism of indirect reduction (Figure 2).65,66 In the presence of
nitrosothiols, ascorbate undergoes a trans-nitrosation reaction
involving nitrosonium (NO1) transfer to generate nitrosoas-
corbate, which decomposes to NO and the semidehydroascor-
bate radical. Therefore, ascorbate does not directly donate an
electron for nitrosothiol reduction. This distinct mechanism is
thought to provide chemical orthogonality to other oxidative
modifications, making ascorbate an ideal nitrosothiol-selective
reducing agent.66 Following ascorbate-mediated reduction, the
newly unmasked thiols groups are then captured using
a pyridyldithiol-activated, sulfhydryl-reactive biotin-linked
probes for affinity enrichment.64 While these reagents are com-
monly available, several commercial kits are available that
include ascorbate, metal-chelating buffers, MMTS, and
FIGURE 2 Biotin-switch technique for ascorbate-dependent reduction of nitrosothiols. Enriched
proteins are either analyzed by SDS–PAGE or annotated by mass spectrometry.
Strategies for Profiling Native SNO 175
Biopolymers
iodoacetamide detection reagents. Recent adaptations for
quantitative proteomics labeling strategies are also commer-
cially available, and have been used to quantify individual sites
of SNO.67 Thiol resin assisted capture (RAC) replaces biotin
and streptavidin purification with direct disulfide capture to
activated thiol resin immediately after ascorbate treatment.68,69
This approach simplifies the procedure, and eliminates non-
specific enrichment of endogenous biotinylated carboxylases.
Ultimately, the biotin-switch purification method is indi-
rect, and highly dependent on the complete alkylation of all
free thiols. Protein nitrosylation is a low abundance modifica-
tion, so even low levels of uncapped thiols can lead to a high
false positive rate. Interestingly, a heating step is generally
included during thiol capping, often to 50C. S-nitrosothiols
are known to undergo thermal decomposition via homolytic
cleavage of the SAN bond to yield the corresponding disulfides
and NO, the latter is then oxidized to nitrogen dioxide.70,71
This step may introduce later complications, as the thermal
stability of distinct nitrosothiols has not been thoroughly eval-
uated. Clearly, prolonged heating will promote NO release,
and potentially suppress detection of labile nitrosothiols. Fur-
thermore, after ascorbate reduction, newly free thiols are able
to exchange with existing disulfide bonds, scrambling native
sites of nitrosylation. RAC is likely to reduce the extent of
scrambling by providing high excess of activated disulfides for
immediate capture.69 Another source of false-positives is sun-
light driven disulfide reduction, which can be eliminated by
performing all procedures in complete darkness.72 This unfor-
tunate restraint makes sample preparation more tedious, but is
essential to eliminate nonspecific disulfide reduction. Overall,
biotin-switch technique is the current standard for nitrosothiol
labeling, enrichment, and analysis.
CAVEATS OF NITRIC OXIDE DONORS
Thousands of S-nitrosylated proteins have been reported from
ascorbate-dependent enrichment using the biotin-switch
method and mass spectrometry.13 Unfortunately, nearly all
reported proteomics data was collected from biological sam-
ples after the addition of exogenous or physiological nitrosylat-
ing agents. Upon donor release, gaseous NO is oxidized by
molecular oxygen to form a peroxynitrite radical, which then
reacts with a second NO molecule to generate two molecules
of nitrogen dioxide. This reaction is limited by an apparent
third-order rate law (k 5 2.5 3 106 M22s21),73–75 which
means the reaction rate depends on the product of square of
the NO concentration and molecular oxygen.73 Therefore, at
very low NO concentrations the reaction is very slow, but at
high NO concentrations the reaction is extremely rapid. Thus,
depending on the concentration of NO released, the half-life of
the reaction can range from 0.5 s to 50 h.73 When donors
release NO at higher than physiological concentrations, it is
likely that nonphysiological nitrosothiols are formed at less
activated thiols. Therefore, it is difficult to interpret the results
of proteomics experiments performed on donor treated
samples.76
In a recent study, two NO donors (spermine NONOate
and CysNO) were compared to understand their ability to
form nitrosothiols.77 Surprisingly, spermine NONOate (t1/2 5
39 and 230 min) produces a high amount of DNIC and very
low amount of nitrosothiols. Conversely, Cys-NO (t1/2  2
min)77,78 efficiently produced nitrosothiols. Since, the majority
of nitrosylation proteomics experiments rely on NO donor-
treated samples, much of the current literature should be care-
fully interpreted. While NO donors are important tools for




Given the limitations of the biotin-switch method, several
alternative approaches have recently been reported (Figure
3A). In a series of innovative reports, Xian presents triaryl-
substituted phosphines as a novel chemoselective reaction for
conversion of nitrosothiols to a stable substituted thiobenza-
mide.79,80 This reductive ligation reaction mechanism is similar
to the Staudinger ligation, and is initiated by nitrosothiol reac-
tion with the phosphine to form an azaylide, which then
undergoes an intramolecular reaction and hydrolysis to yield
the substituted thiobenzamide adduct. Additional variants of
this reaction proceed by a similar azaylide intermediate, but
undergo distinct rearrangements to yield varying products.
The bis-ligation reaction uses phosphine-thioester probes to
form disulfide-iminophosphorane products.81 Importantly, the
nitrogen originating from NO transforms to the iminophos-
phorane, providing an analytical linkage to both the originat-
ing NO and thiol. This methodology has been used to quantify
the formation of S-nitrosoglutathione in activated macro-
phages by mass spectrometry, and allowed sensitive profiling
of other nitrosylated metabolites in cell lysates.82 The one-step
disulfide method similarly uses a phosphine-thioester to first
form the thiobenzamide adduct and thiolate, followed by
intermolecular thioester exchange with the released thiolates to
generate a disulfide linkage.81 The reaction results in disulfide
formation and elimination of the phosphine oxide. Finally,
alkyl-aryl phosphines react with SNO generation of the azay-
lide, followed by reductive elimination to generate dehydroala-
nine.83 Dehydrolalanine is an electrophilic Michael acceptor,
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and can be linked to a variety of tagged nucleophiles for
straightforward chemoselective enrichment.
In cell lysates, excess phosphine reagent led to complete
reduction of nitrosothiols to free thiols,79 suggesting these
methods may require careful optimization. To avoid this pitfall,
free thiols were first alkylated with NEM, followed by selective
nitrosothiol reduction with triaryl-phosphines. The resulting
free thiols were labeled using biotin or fluorophore-linked mal-
eimide reagents for nitrosothiol detection. In gel-based experi-
ments, phosphine reduction demonstrated superior selectivity
to dithiothreitol, which nonselectively reduced disulfides and
sulfenylated thiols.79 This methodology was used in fixed cells
to detect nitrosothiols after lipopolysaccharide stimulation in
macrophages. Overall, these mechanistic phosphine probes
show early promise as an alternative to ascorbate-dependent
enrichment and proteomic analysis.
Organo-mercury enrichment methods have emerged as
an alternative approach for direct nitrosothiol labeling and
enrichment84,85 (Figure 3B). Nitroso-cysteines react directly
with phenylmercury to yield a stable thiol-mercury bond.
This reaction is direct, selective, and highly efficient. By
coupling the phenyl mercury to biotin or agarose beads,
nitrosothiols can be directly labeled and enriched from tis-
sue lysates. Bound peptides are then released from the resin
by mild performic acid treatment, which oxidizes the thiol
to the sulfonic acid for selective detection by mass spec-
trometry.85 The fate of MMTS-capped thiols is not
reported, although they are presumably simultaneously
FIGURE 3 Chemoselective nitrosothiol labeling methods. In both approaches, free thiols are first
blocked by addition of MMTS. (A) Triaryl-phosphine ligation methods. Three reactions are shown
that describe recent reports of nitrosothiol-selective phosphine reactions. The reductive ligation
approach was demonstrated on fixed cells, but led to over-reduction to the free thiol. The one-step
disulfide formation reaction was demonstrated on cell lysates after nitric oxide donor treatment.
(B) Phenyl-mercury enrichment of nitrosothiols for proteomic annotation. Sepharose beads or bio-
tin are linked to phenyl-mercury for nitrosothiol enrichment, followed by trypsin digestion. Nitro-
sylated peptides are released from the resin by perfomic acid oxidation to the sulfonic acid for mass
spectrometry annotation.
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oxidized. This suggests MMTS should be replaced with
iodoacetamide reagent to block free thiols before analysis.
Furthermore, methionine is similarly oxidized by perfomic
acid to the sulfone, adding additional complexity to the
proteomic analysis. Nonetheless, this method lead to the
identification of nearly a thousand nitrosylation sites
summed across mouse brain, heart, liver, kidney, lung, and
thymus tissues. Furthermore, about half or more of these
sites were absent in eNOS knockout mice, suggesting the
majority of nitrosylation originates from NO synthases.84
Interestingly, more than 70% of the nitrosylation sites in
heart tissue were found on mitochondrial proteins.84 Fur-
ther analysis suggests widespread regulation of metabolic
enzymes in involved in glycolysis, gluconeogenesis, pyru-
vate metabolism, the Kreb’s cycle, oxidative phosphoryla-
tion, amino acid metabolism, ketone body formation, and
fatty acid pathways. The simplicity of this method offers
several advantages over ascorbate-dependent capture meth-
ods, particularly since it is a direct enrichment followed by
a unique oxidation to sulfonate for direct proteomic anno-
tation. Furthermore, this method is the first to report
robust differences by comparative proteomic analysis of
eNOS knockout mice. This data provides key evidence that
NO synthase activation contributes to nitrosylation in vivo,
and suggests supplementation with NO donors could have
broader implications on cellular metabolism.
CONCLUSIONS
Protein SNO has emerged as an important oxidative post-
translational modification. Several labeling methods have
emerged that take advantage of the unique reactivity, either by
reduction and capture, or by direct chemical labeling. Impor-
tantly, such methodologies have enabled proteomic analysis of
SNO in cells and tissues. In conjunction with isotopic labeling
methods, quantitative proteomic profiling of SNO will enable
in-depth global profiling, independent of NO donors. With
the development of selective methods for each distinct cysteine
post-translational modification, multiplexed analysis has the
potential to discover new cellular pathways orchestrated post-
translational exchanges. Such analysis will integrate palmitoyl-
ation dynamics, and explore the mutual competition at distinct
cysteine residues between NO and hydrogen peroxide. Impor-
tantly, each of these modifications are labile, and rapidly
hydrolyzed in the presence of free thiols, such as glutathione.
Therefore, we anticipate such tools will enable a greater under-
standing of the role of compartmentalization in thiol modifica-
tion stability and function.
The authors would like to thank Mi Hee Lim (U. Michigan) and
members of the Martin lab for helpful discussions.
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